Ivermectin had no clinical benefit against COVID-19 in largest study so far (NYSE:MRK)

A group of researchers evaluating the effect of repurposed drugs against COVID-19 found that antiparasitic medication ivermectin did not improve patient outcomes in the largest trial of...

Related Keywords

Brazil , ,National Institutes Of Health ,Drug Administration ,Canada Mcmaster University ,Wall Street Journal ,Edward Mills ,Mcmaster University ,National Institutes ,